PTC Therapeutics (PTCT) Misses Q1 EPS by 24c

PTC Therapeutics (NASDAQ: PTCT) reported Q1 EPS of ($1.78), $0.24 worse than the analyst estimate of ($1.54). Revenue for the quarter came in at $148.73 million versus the consensus estimate of $146.9 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery